Cerevel Therapeutics Holdings Inc CERE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
42.24UNCH (UNCH)
Volume
130,753
Close
42.24quote price arrow up+0.18 (+0.43%)
Volume
596,017
52 week range
19.59 - 43.59
Loading...
  • Open42.19
  • Day High42.29
  • Day Low41.94
  • Prev Close42.06
  • 52 Week High43.59
  • 52 Week High Date02/15/24
  • 52 Week Low19.59
  • 52 Week Low Date10/04/23

Key Stats

  • Market Cap7.683B
  • Shares Out181.89M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-0.38

KEY STATS

  • Open42.19
  • Day High42.29
  • Day Low41.94
  • Prev Close42.06
  • 52 Week High43.59
  • 52 Week High Date02/15/24
  • 52 Week Low19.59
  • 52 Week Low Date10/04/23
  • Market Cap7.683B
  • Shares Out181.89M
  • 10 Day Average Volume0.97M
  • Dividend-
  • Dividend Yield-
  • Beta1.45
  • YTD % Change-0.38

RATIOS/PROFITABILITY

  • EPS (TTM)-2.72
  • P/E (TTM)-15.52
  • Fwd P/E (NTM)-16.62
  • EBITDA (TTM)-484.523M
  • ROE (TTM)-92.45%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)59.87%

EVENTS

  • Earnings Date07/31/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Cerevel Therapeutics Holdings Inc

 

Profile

MORE
Cerevel Therapeutics Holdings, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on neuroscience that combines an understanding of disease-related biology and neurocircuitry of the brain with advanced chemistry and central nervous system (CNS) target receptor selective pharmacology to discover and design new therapies. It focuses on transform the lives of patients through the development of new therapies for neuroscience diseases, including...
N. Coles Jr., M.D.
Chairperson of the Board of Directors
Ronald Renaud Jr.
President, Chief Executive Officer, Member of the Board
Susan Altschuller Ph.D.
Chief Financial Officer
Address
222 Jacobs Street, Suite 200
Cambridge, MA
02141
United States

Top Peers

SYMBOLLASTCHG%CHG
VKTX
Viking Therapeutics Inc
72.50+0.15+0.21%
PCVX
Vaxcyte Inc
67.33+1.63+2.48%
CYTK
Cytokinetics Inc
59.36+1.47+2.54%
RVMD
Revolution Medicines Inc
37.38+0.21+0.56%
ASND
Ascendis Pharma A/S
124.82-7.20-5.45%